Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Probiotics in Childhood Abdominal Pain
Brief Summary: The purpose of this study is to assess the effect of probiotics in childhood recurrent abdominal pain. Patients will be randomly assigned to receive L. reuteri or placebo for 4 weeks with a follow up phase of additional 4 weeks.


Options:
A: Arm Label: Probiotic/abdominal pain; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Administration of L.reuteri in children with abdominal pain | Arm Label: Placebo/abdominal pain; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Administration of placebo in children with abdominal pain | Arm Label: Probiotic/constipation; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Administration of L.reuteri in children with constipation | Arm Label: Placebo/chronic constipation; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Administration of placebo in children with constipation | Intervention Type: DIETARY_SUPPLEMENT; Name: Administration of L.reuteri in children with abdominal pain; Assigned to Arm(s): Probiotic/abdominal pain | Intervention Type: DIETARY_SUPPLEMENT; Name: Administration of placebo in children with abdominal pain; Assigned to Arm(s): Placebo/abdominal pain | Intervention Type: DIETARY_SUPPLEMENT; Name: Administration of L.reuteri in children with constipation; Assigned to Arm(s): Probiotic/constipation | Intervention Type: DIETARY_SUPPLEMENT; Name: Administration of placebo in children with constipation; Assigned to Arm(s): Placebo/chronic constipation
B: Arm Label: Probiotics(Medirac) 10/mosapride 10mg; Type: EXPERIMENTAL; Interventions: Drug: Probiotics (Medirac) | Arm Label: Probiotics(Medirac) 15/mosapride 10mg; Type: EXPERIMENTAL; Interventions: Drug: Probiotics (Medirac) | Arm Label: Probiotics(Medirac) 15/mosapride 15mg; Type: EXPERIMENTAL; Interventions: Drug: Probiotics (Medirac) | Arm Label: Probiotics(Medirac) 30/mosapride 15mg; Type: EXPERIMENTAL; Interventions: Drug: Probiotics (Medirac) | Arm Label: Probiotics(Medirac) placebo/mosapride placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Probiotics (Medirac) placebo/mosapride placebo | Intervention Type: DRUG; Name: Probiotics (Medirac); Assigned to Arm(s): Probiotics(Medirac) 10/mosapride 10mg | Intervention Type: DRUG; Name: Probiotics (Medirac); Assigned to Arm(s): Probiotics(Medirac) 15/mosapride 10mg | Intervention Type: DRUG; Name: Probiotics (Medirac); Assigned to Arm(s): Probiotics(Medirac) 15/mosapride 15mg | Intervention Type: DRUG; Name: Probiotics (Medirac); Assigned to Arm(s): Probiotics(Medirac) 30/mosapride 15mg | Intervention Type: DRUG; Name: Probiotics (Medirac) placebo/mosapride placebo; Assigned to Arm(s): Probiotics(Medirac) placebo/mosapride placebo
C: Arm Label: Mixture of three Bifidobacteria; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mixture of three Bifidobacteria | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Mixture of three Bifidobacteria | Intervention Type: DRUG; Name: Mixture of three Bifidobacteria; Assigned to Arm(s): Mixture of three Bifidobacteria, Placebo
D: Arm Label: Probiotics supplementation; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Probiotics | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotics; Assigned to Arm(s): Probiotics supplementation | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D